-+ 0.00%
-+ 0.00%
-+ 0.00%

MARKER THERAPEUTICS - FUNDING TO SUPPORT PHASE 1 STUDY OF MT-601 IN PANCREATIC CANCER

Reuters·10/19/2026 11:00:02

Please log in to view news